SCHEMBL5285837

SCHEMBL5285837

O=C(O)CC(c1ccccc1)n1cnc2ccc(NC(=O)c3ccc(Br)s3)cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 12/20 0.45
RAB9A P51151 12/20 0.45
CASP3 P42574 2/20 0.45
SENP7 Q9BQF6 2/20 0.45
SMN1; SMN2 Q16637 8/20 0.41
KMT2A Q03164 7/20 0.41
MEN1 O00255 6/20 0.41
NFKB1 P19838 3/20 0.41
NFKB2 Q00653 3/20 0.41
RELA Q04206 3/20 0.41
POLB P06746 2/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
MITF O75030 1/20 0.40
MAPT P10636 3/20 0.40
TP53 P04637 1/20 0.40
ALOX15 P16050 1/20 0.40
MAPK1 P28482 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5291889 0.93 NPC1 (0.47) NPC1RAB9ACASP3SENP7SMN1; SMN2
SCHEMBL2294478 0.84 NPC1 (0.48) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL2297005 0.84 MAPT (0.49) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL2298688 0.84 NPC1 (0.48) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL2298655 0.82 RAB9A (0.48) NPC1RAB9ACASP3SENP7SMN1; SMN2
SCHEMBL2299723 0.82 GRM4 (0.48) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL5284873 0.81 GAA (0.37) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL2299591 0.81 MAPT (0.52) NPC1RAB9ACASP3SENP7SMN1; SMN2
SCHEMBL2292264 0.81 NPC1 (0.44) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL2295598 0.81 MEN1 (0.43) NPC1RAB9ASMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828144-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI Pharmaceuticals, Inc. (US) 2007-09-05 EP claimed
WO-2006053342-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI PHARMACEUTICALS, INC. (US) 2006-05-18 WO claimed